Triptolide from Tripterygium wilfordii Shows Promising Results in Breast Cancer Research

Strategic Insights -

Scientists from Nanjing, China, have made significant discoveries in breast cancer research, particularly in understanding the effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in human breast cancer cell lines. The study, published in Phytomedicine, aimed to investigate the differential cytotoxicity of triptolide towards estrogen-sensitive and estrogen-insensitive breast cancer cells. The results showed that triptolide is more potent in estrogen-sensitive MCF-7 cells, causing significant anti-proliferation effects, cell cycle arrest, and apoptosis, whereas estrogen-insensitive MDA-MB-231 cells required a higher concentration of triptolide to induce similar effects.

Key Takeaways:

  • Triptolide from Tripterygium wilfordii showed potent anti-proliferation effects in estrogen-sensitive MCF-7 breast cancer cells, with an IC50 value one-tenth of that in estrogen-insensitive MDA-MB-231 cells.
  • The study found that the sensitivity of breast cancer cells to triptolide is significantly associated with the expression of ERalpha and p53.
  • Triptolide caused cell cycle arrest and apoptosis in MDA-MB-231 cells at a concentration of 400nM, whereas MCF-7 cells showed significant effects at 40nM.
  • The expression of wild-type p53 in MCF-7 cells was increased, and mutant p53 in MDA-MB-231 cells was suppressed in response to triptolide treatment.
  • Triptolide was found to downregulate the expression of ERalpha in MCF-7 cells.

Statistics:

  • IC50 value in MCF-7 cells: approximately 40nM
  • IC50 value in MDA-MB-231 cells: approximately 400nM
  • Concentration of triptolide required to induce cell cycle arrest and apoptosis in MDA-MB-231 cells: 400nM
  • Concentration of triptolide required to induce significant effects in MCF-7 cells: 40nM
  • Percentage of cells in sub-G0/G1 phase after triptolide treatment: 20-30% in MDA-MB-231 cells and 5-10% in MCF-7 cells

Sources:

  • Liu, J., et al. "Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines." Phytomedicine, vol. 16, no. 11, 2009, pp. 1006-13.
  • National Center of Drug Screening, China Pharmaceutical University, Nanjing, China.